4-FMA

From PsychonautWiki
Jump to: navigation, search
Yellow-warning-sign1.svg

This page has not been approved by the PsychonautWiki administrators.

It may potentially contain incorrect information, particularly regarding that of dosage, duration, subjective effects, toxicity and other risks.

Summary sheet: 4-FMA
4-FMA
4-FMA.svg
Chemical Nomenclature
Common names 4-FMA
Substitutive name 4-Fluoromethamphetamine
Systematic name 1-(4-Fluorophenyl)-N-methylpropan-2-amine
Class Membership
Psychoactive class Stimulant / Entactogen
Chemical class Amphetamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Threshold 10 - 25 mg
Light 25 - 50 mg
Common 50 - 75 mg
Strong 100 - 125 mg
Heavy 125 mg +
Duration
Total 4 - 8 hours
Onset 20 - 40 minutes
Come up 20 - 40 minutes
Peak 2 - 5 hours
Offset 1 - 2 hours
After effects 3 - 12 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

4-Fluoromethamphetamine (abbreviated 4-FMA) is a synthetic substituted amphetamine with stimulant, entactogenic and purported nootropic effects. Many users describe it subjectively as displaying properties and effects somewhere in spectrum between 4-FA and 2-FMA, but with subtle variations in its pharmacodynamics, kinetics and side effect profile that make it less desirable than either.[1]

4-FMA is rarely found on the street and is usually sold as a rare grey area research chemical through online vendors, occasionally along with related designer stimulants such as 2-fluoroamphetamine (2-FA), 3-fluoroamphetamine (3-FA) and 4-fluoroamphetamine (4-FA).[2][3]. Of these, it is one of the least potent and popular fluorinated designer amphetamine in the series.

Chemistry

4-Fluoromethamphetamine (4-FMA) is a synthetic molecule of the substituted amphetamine family. Molecules of this class contain a phenethylamine core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at Rα. The term "amphetamine" is the contracted form of alpha-methylphenethylamine. 4-fluoromethamphetamine contains a fluorine atom at R4 of its phenyl ring and is therefore a fluorinated analogue of methamphetamine.

Pharmacology

Similar to its structural analog 4-FA, 4-Fluoromethamphetamine is thought to act as a releasing agent and reuptake inhibitor of dopamine, serotonin, and norepinephrine, producing stimulating amphetamine-like effects at lower doses and moderate euphoric, entactogenic effects similar to MDMA at dosages above 125mg, albeit much less mild.[citation needed] The mechanism of action of 4-FMA effectively boosts the levels of the norepinephrine, dopamine, and serotonin neurotransmitters in higher doses in the brain by binding to and partially blocking the transporter proteins that normally clear these monoamines from the synaptic cleft. This allows dopamine, norepinephrine, and serotonin to accumulate within various regions of the brain, including its reward pathways, resulting in stimulating, euphoric and entactogenic effects.[4][5][6]

Subjective effects

In low doses, 4-FMA has been reported to be a moderately functional nootropic for performing tasks or general productivity.[citation needed] At higher dosages, however, it is known to become dysfunctional and recreational due to the scattering quality of its euphoria and stimulation.[citation needed] Unlike its unmethylated analog 4-FA, which presents a distinct entactogenia that feels somewhat similar to MDMA during the initial part of the experience, the subjective effects of 4-FMA are more reminiscent of the effects characteristic of 2-FMA, with its marked dose-ceiling and classical stimulant effects.[citation needed] However, some reports suggest it tends to come with more side effects and bodily strain than other fluorinated amphetamines, explaining its lack of popularity and availability.[citation needed]

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects should be taken with a grain of salt and will rarely (if ever) occur all at once, but heavier doses will increase the chances and are more likely to induce a full range of effects. Likewise, adverse effects become much more likely on higher doses and may include serious injury or death.

Do not use 4-FMA if you have a history of heart-related issues or experience severe headache after its use. We have been made aware of a report released by Trimbos-instituut[7] and Nationaal Vergiftigingen Informatie Centrum[8] (NVIC), describing incidents of strokes after an increased use of the closely related analogue 4-FA, and there is no reason this does not apply to 4-FMA as well. In addition to the common amphetamine-like effects (agitation, anxiety, tachycardia, hypertension, chest pain et al.), serious cardio- and cerebrovascular complications have been reported, including rhythm (sinus arrhythmia, ventricular extrasystoles (bigeminy), conduction disturbances) and acute cardiac failure. Although a causal relationship has not been confirmed, when presented with a severe headache and lateralization after 4-FA usage, a medical evaluation at an emergency department should be conducted immediately. [9]


Physical effects
Child.svg

After effects
Aftereffects (3).svg

Cognitive effects
User.svg

Experience reports

Anecdotal reports which describe the effects of this compound within our experience index include:

Additional experience reports can be found here:

Toxicity and harm potential

The toxicity and long-term health effects of recreational 4-FMA use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 4-FMA has very little history of human usage. Anecdotal evidence from people who have tried 4-FMA within the community suggests that there do not seem to be any negative health effects attributed to simply trying this drug at low to moderate doses by itself and using it sparingly (but nothing can be completely guaranteed).

The LD50 (mouse; i.p.) of 4-FMA is unknown. While 4-FA does not cause long-lasting depletion of brain serotonin unlike MDMA or 4-FA's analogs 4-CA and 4-BA, it is unknown whether this also applies to 4-FMA as well.

It is also worth noting that 4-FMA is particularly caustic in comparison to other compounds and can, therefore, cause chemical burns within the nasal passage and throat if it is insufflated.

It is strongly recommended that one use harm reduction practices when using this drug.

Tolerance and addiction potential

As with other stimulants, the chronic use of 4-FMA can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage.

Tolerance to many of the effects of 4-FMA develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). This is how long it takes to reduce the tolerance for the stimulating effects. Tolerance for the entactogenic effects may take a longer period to reduce. 4-FA presents cross-tolerance with all dopaminergic stimulants, meaning that after the consumption of 4-FMA all stimulants will have a reduced effect.

Psychosis

Main article: Stimulant psychosis

Abuse of compounds within the amphetamine chemical class at high dosages for prolonged periods of time can potentially result in a stimulant psychosis that may present with a variety of symptoms (e.g., paranoia, hallucinations, or delusions).[10] A review on treatment for amphetamine, dextroamphetamine, and methamphetamine abuse-induced psychosis states that about 5–15% of users fail to recover completely.[11][12] The same review asserts that, based upon at least one trial, antipsychotic medications effectively resolve the symptoms of acute amphetamine psychosis.[13] Psychosis very rarely arises from therapeutic use.[14][15]

Dangerous interactions

Although many drugs are safe on their own, they can become dangerous and even life-threatening when combined with other substances. The list below contains some common potentially dangerous combinations, but may not include all of them. Certain combinations may be safe in low doses of each but still increase the potential risk of death. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.

Serotonin syndrome risk

Combinations in the list below may increase the amount of neurotransmitters such as serotonin and dopamine to dangerous or even fatal levels.

Legal issues

Handcuffs-300px.png

This legality section is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

  • United Kingdom: 4-fluoromethamphetamine is a Class A drug under the Misuse of Drugs Act. 4-FMA is covered by the 1977 addition to the Misuse of Drugs Act of 1971.[citation needed]
  • China - As of October 2015 4-FMA is a controlled substance in China.[17]
  • Canada: 4-FMA would be considered Schedule I as it is an analogue of Amphetamine.[18]
  • New Zealand: 4-FMA is an amphetamine analogue, so is a Schedule 3 controlled substance in New Zealand.[19]

See also

External links

References

  1. 4-fluoromethamphetamine (Bluelight) | http://web.archive.org/web/20141215224213/http://www.bluelight.org/vb/threads/356585-4-fluoromethamphetamine
  2. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17223101
  3. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs). (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/15639609
  4. http://www.sciencedirect.com/science/article/pii/0028390875900994 | Comparison of 4-chloro-, 4-bromo-and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotonin metabolism
  5. http://www.sciencedirect.com/science/article/pii/S0014299906013811
  6. http://www.sciencedirect.com/science/article/pii/S0014299906013811 | The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain
  7. https://www.trimbos.nl/
  8. https://www.vergiftigingen.info/
  9. https://psychonautwiki.org/wiki/File:Behandeling-4-fa-intoxicatie.pdf
  10. Treatment for amphetamine psychosis | [1]
  11. Treatment for amphetamine psychosis | [2]
  12. Hofmann FG (1983). A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects (2nd ed.). New York: Oxford University Press. p. 329. ISBN 9780195030570.
  13. Treatment for amphetamine psychosis | [3]
  14. Stimulant Misuse: Strategies to Manage a Growing Problem | http://www.acha.org/prof_dev/ADHD_docs/ADHD_PDprogram_Article2.pdf
  15. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021303s026lbl.pdf
  16. Gillman, P. K. (2005). Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 95(4), 434-441. https://doi.org/10.1093/bja/aei210
  17. "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015. 
  18. Controlled Drugs and Substances Act (S.C. 1996, c. 19) |http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-12.html#h-28
  19. http://www.legislation.govt.nz/act/public/1975/0116/latest/whole.html#DLM436576